Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain

Central Neuropathic Pain Clinical Trial

Official title:
A 13-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety And Tolerability Of Pregabalin (150-600 Mg/Day) Using A Flexible Dosing Schedule In The Treatment Of Subjects With Central Post-Stroke Pain (CPSP)

Status Completed

Clinical Trial Summary

Efficacy and Safety of flexibly dosed pregabalin compared to placebo among subjects with central post stroke pain (CPSP)

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00313820
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 4
Start date	August 2006
Completion date	September 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01324232` - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis	Phase 2
Recruiting	`NCT06071949` - Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis	Phase 3
Recruiting	`NCT06072001` - Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis	Phase 3
Recruiting	`NCT05357066` - Nitrous Oxide as Treatment for Fibromyalgia	Phase 2
Completed	`NCT03901352` - Study of Mirogabalin for Central Neuropathic Pain	Phase 3
Not yet recruiting	`NCT04665492` - EEG Predictors of Neuropathic Pain in SCI
Completed	`NCT02218203` - Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial	Phase 2